Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sofiva Genomics Co., Ltd. (6615:TWSE), powered by AI.
Sofiva Genomics Co., Ltd. is currently trading at $34.60. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sofiva Genomics Co., Ltd. on Alpha Lenz.
View Sofiva Genomics Co., Ltd.'s valuation metrics on Alpha Lenz.
“Sofiva Genomics Co., Ltd.'s ROE is -1.5%. Explore profitability and growth together.”
Ask for details →Sofiva Genomics Co., Ltd. is a Taiwan-based provider of medical and genetic testing services, specializing in pre-pregnancy, prenatal, and newborn genetic diagnostics. Established in 2012 and headquartered in Taipei, the company focuses on advanced reproductive medicine, cancer genomics, rare disease screening, and personalized genetic analyses, serving hospitals, clinics, and individual clients. Its offerings include pre-implantation genetic diagnosis, predictive testing for preeclampsia, neonatal screenings for hearing loss and congenital infections, as well as panels for chronic diseases and cancer susceptibility. Sofiva Genomics plays a vital role in enabling precision medicine and preventive healthcare in the region, combining laboratory expertise with genetic counseling services to support informed health decisions. As part of Taiwan’s dynamic biotechnology and medical research sector, the company contributes to innovation in genetic testing, helping advance population health and healthcare efficiency through its specialized diagnostics and research-driven approach.
“Sofiva Genomics Co., Ltd.'s ROE is -1.5%. Explore profitability and growth together.”
Ask for details →Sofiva Genomics Co., Ltd. (ticker: 6615) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).
The current price is 34.6 with a P/E ratio of -x and P/B of -x.
ROE is -1.47% and operating margin is -8.74%. Annual revenue is $386M.